← FDA Drug Approvals (Drugs@FDA)
NEOSTIGMINE METHYLSULFATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2018-06-15
Drug application
- FDA Application #
ANDA210051- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NEOSTIGMINE METHYLSULFATE
- Generic name
- NEOSTIGMINE METHYLSULFATE
- Active ingredients
- NEOSTIGMINE METHYLSULFATE
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- AMNEAL
- Manufacturer
- Amneal Pharmaceuticals LLC
- First approval
- 2018-06-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown